Serial Diluters. lol
So Typical,
Name changes, business model changes, symbol changes.
They were in fruit sterilization, then medical maryjane, then whatever and now pancreatic cancer cures. lol, these guys just look for the next hot thing and acquire other serial diluters to keep the game going while they collect huge salaries from all the dilution. 1/2 billion shares outstanding already. They have another year of dilution before the reverse split, what a joke. all in my opinion.
NOTE 10 - COMMON STOCK TRANSACTIONS
During the year ended April 30, 2012, 500,000 shares of common stock were issued in exchange for $21,000 cash.
During the year ended April 30, 2012, 14,605,614 shares of common stock were issued for stock previously granted and recorded for
compensation and services.
During the year ended April 30, 2012, 23,575,000 shares of common stock were issued to officers of the Company for compensation. Shares were
valued using the closing stock price on the day of issuance for a total expense of $1,160,880 .
During the year ended April 30, 2012, 8,550,000 shares of common stock were issued for various services. Shares were valued using the closing
stock price on the day of issuance for a total expense of $409,400 .
During the year ended April 30, 2012, 9,250,000 shares of common stock were issued in exchange for $600,000 in cash advances to the Company.
In addition, another 1,650,000 shares were issued as incentive for providing the cash advances to the Company. These additional shares were
value at $101,750 and charged to interest expense
During the year ended April 30, 2012, 1,025,000 shares of common stock were issued to settle various debts. The shares were valued using the
closing stock price on the day of issuance for a total expense of $55,725 .
During the year ended April 30, 2013, 8,771,429 shares of common stock were issued for various services. Shares were valued using the closing
stock price on the day of issuance for a total expense of $331,000 .
During the year ended April 30, 2013, 3,592,656 shares of common stock were issued to settle various debts. The shares were valued using the
closing stock price on the day of issuance for a total expense of $143,596 .
During the year ended April 30, 2013, 13,326,668 shares of common stock were issued to officers of the Company for compensation. Shares were
valued using the closing stock price on the day of issuance for a total expense of $653,696 .
AI
